GGrantIndex
Sort

326,823 grants matching clinical trial

Phase 3 trial of inosine for Parkinson's disease CCC

$2,874,019
Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2018 · NS

Community Clinical Oncology Program

$2,873,981
Charles L Loprinzi · Mayo Clinic Rochester · U10 · FY2013 · CA

University of North Carolina Global HIV Prevention and Treatment Clinical Trials

$2,873,337
Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2018 · AI

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

$2,873,279
Ying Yuan · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · DK

Wisconsin NCI Community Oncology Research Program (WiNCORP)

$2,873,002
Adedayo A Onitilo · Marshfield Clinic Research Foundation · UG1 · FY2022 · CA

(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV

$2,872,207
Scott G Kitchen · University Of California Los Angeles · U19 · FY2020 · AI

ID-CTP Clinical Core

$2,872,174
Sung-Yun Pai · Division Of Basic Sciences - Nci · ZID · FY2023 · CA

DATA CORE (DC)

$2,871,567
Ronald G. Thomas · University Of California, San Diego · U01 · FY2009 · AG

Engineering T cells to Provide Durable Control of HIV-1 Replication

$2,871,467
James L Riley · University Of Pennsylvania · U19 · FY2020 · AI

Emory HIV/AIDS Clinical Trials Unit

$2,871,438
Jeffrey Lennox · Emory University · U01 · FY2009 · AI

Cancer Center Administration

$2,871,106
Matthew Howard Huesser · Thomas Jefferson University · P30 · FY2023 · CA

1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

$2,870,887
Frank W Moler · University Of Michigan At Ann Arbor · UG3 · FY2021 · HL

Restoring Blood-Brain Function to Improve Cognition in Alzheimer's Disease

$2,870,472
Anika M.s. Hartz · University Of Kentucky · RF1 · FY2018 · AG

ID-CTP Clinical Core

$2,869,853
Sung-Yun Pai · Division Of Basic Sciences - Nci · ZID · FY2025 · CA

Prevention of Alzheimer Dementia and Cognitive Decline

$2,869,813
John C S Breitner · Seattle Inst For Biomedical/Clinical Res · U01 · FY2010 · AG

Johns Hopkins-Tufts Trial Innovation Center

$2,869,346
Daniel F Hanley · Johns Hopkins University · U24 · FY2021 · TR

Disrupted Adenovirus Serotype 5-based Anti-cocaine Vaccine

$2,868,677
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2012 · DA

Clinical Trials of Biodefense Vaccines (Dengue, West Nile Virus, TBEV)

$2,868,147
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

DAIT CLINICAL SITE MONITORING CENTER

$2,868,026
Mary Glessner · Ppd Development Lp · N01 · FY2020 · AI

Modulation of Cerebellar Activity by Electrical and Focused Ultrasound Stimulation

$2,867,935
Mesut Sahin · New Jersey Institute Of Technology · RF1 · FY2022 · NS

Hyperthermia and Perfusion Effects in Cancer Therapy

$2,867,786
Mark Wesley Dewhirst · Duke University · P01 · FY2008 · CA

Autonomic Pharmacodynamic Pharmacogenomics

$2,867,651
University Of California San Diego · U01 · FY2002 · HL

Data Resource for Analyzing Blood &Marrow Transplants

$2,867,577
Medical College Of Wisconsin · U24 · FY2004 · CA

Community Clinical Oncology Program

$2,867,539
Charles L Loprinzi · Mayo Clinic Rochester · U10 · FY2012 · CA

NIDA Clinical Trials Network: New York Node

$2,867,419
Jennifer McNeely · New York University School Of Medicine · UG1 · FY2023 · DA